Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing.

A multi-inlet microfluidic hydrodynamic focusing (MF) system to prepare lipopolyplex (LP) containing Bcl-2 antisense deoxyoligonucleotide (ODN) was developed and evaluated. The lipopolyplex nanoparticles consist of ODN:protamine:lipids (1:0.3:12.5wt/wt ratio) and the lipids included DC-Chol:egg PC:PEG-DSPE (40:58:2mol/mol%). Using K562 human erythroleukemia cells, which contain an abundance of Bcl-2 and overexpression of transferrin receptors (TfR), and G3139 (oblimerson sodium or Genasense(TM)) as a model cell line and drug, respectively, the Bcl-2 down-regulation at the mRNA and protein levels as well as cellular uptake and apoptosis was compared between the conventional bulk mixing (BM) method and the MF method. The lipopolyplex size and surface charge were characterized by dynamic light scattering (DLS) and zeta potential (zeta) measurement, respectively, while the ODN encapsulation efficiency was determined by gel electrophoresis. Cryogenic transmission electron microscopy (Cryo-TEM) was used to determine the morphology of LPs. Our results demonstrated that MF produced LP nanoparticles had similar structures but smaller size and size distribution compared to BM LP nanoparticles. MF LP nanoparticles had higher level of Bcl-2 antisense uptake and showed more efficient down-regulation of Bcl-2 protein level than BM LP nanoparticles.

[1]  G. Marcucci,et al.  Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Z Hugh Fan,et al.  Integrating polymerase chain reaction, valving, and electrophoresis in a plastic device for bacterial detection. , 2003, Analytical chemistry.

[3]  N. Dias,et al.  Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  Wyatt N Vreeland,et al.  Microfluidic directed formation of liposomes of controlled size. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[5]  Anatoly Snigirev,et al.  Microfluidics of soft matter investigated by small-angle X-ray scattering. , 2005, Journal of synchrotron radiation.

[6]  J. Byrd,et al.  Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. , 2009, Molecular pharmaceutics.

[7]  Z. Hugh Fan,et al.  Integrating polymerase chain reaction, valving, and electrophoresis in a plastic device for bacterial detection. , 2003, Analytical chemistry.

[8]  Y. Niitsu,et al.  In vivo gene delivery to tumor cells by transferrin‐streptavidin‐DNA conjugate , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Zimmer,et al.  Antisense delivery using protamine-oligonucleotide particles. , 2000, Nucleic acids research.

[10]  D. Weitz,et al.  Geometrically mediated breakup of drops in microfluidic devices. , 2003, Physical review letters.

[11]  D. Banerjee.  Technology evaluation: G-3139. , 1999, Current opinion in molecular therapeutics.

[12]  D. Cunningham,et al.  BCL-2 antisense therapy in patients with non-Hodgkin lymphoma , 1997, The Lancet.

[13]  Howard A. Stone,et al.  ENGINEERING FLOWS IN SMALL DEVICES , 2004 .

[14]  Wyatt N Vreeland,et al.  Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. , 2004, Journal of the American Chemical Society.

[15]  P. Cullis,et al.  Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. , 2001, Biophysical journal.

[16]  Y. Barenholz,et al.  Nanostructure of cationic lipid-oligonucleotide complexes. , 2004, Biophysical journal.

[17]  M. Caligiuri,et al.  Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia. , 2008, Blood.

[18]  E. Chang,et al.  Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. , 1999, Human gene therapy.

[19]  A. Buléon,et al.  Ultrastructural aspects of phytoglycogen from cryo-transmission electron microscopy and quasi-elastic light scattering data. , 1999, International journal of biological macromolecules.

[20]  P. Iversen.  In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. , 1991, Anti-cancer drug design.

[21]  H. Stone,et al.  Formation of dispersions using “flow focusing” in microchannels , 2003 .

[22]  L. Seymour.  Passive tumor targeting of soluble macromolecules and drug conjugates. , 1992, Critical reviews in therapeutic drug carrier systems.

[23]  L. Jeffs,et al.  A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA , 2005, Pharmaceutical Research.

[24]  S. Köster,et al.  Evolution of DNA compaction in microchannels , 2006 .

[25]  S. Quake,et al.  Dynamic pattern formation in a vesicle-generating microfluidic device. , 2001, Physical review letters.

[26]  A. Zimmer,et al.  Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles. , 2006, Oligonucleotides.